H.R.3925 - Prescription Drug Price Monitoring Commission Act of 1998105th Congress (1997-1998)
|Sponsor:||Rep. Berry, Marion [D-AR-1] (Introduced 05/21/1998)|
|Committees:||House - Ways and Means; Commerce|
|Latest Action:||House - 06/05/1998 Referred to the Subcommittee on Health and Environment, for a period to be subsequently determined by the Chairman. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: H.R.3925 — 105th Congress (1997-1998)All Information (Except Text)
Introduced in House (05/21/1998)
Prescription Drug Price Monitoring Commission Act of 1998 - Establishes the Prescription Drug Price Monitoring Commission which shall conduct specified studies concerning U.S. pharmaceutical prices, including the establishment of a pharmaceutical products price review board. Terminates the Commission on a specified date.
Directs the Secretary of Health and Human Services to study and report on Federal subsidies and incentives provided to the pharmaceutical industry.
Amends title XIX (Medicaid) of the Social Security Act to require drug manufacturers participating in the Medicaid rebate program to report within a certain time after the end of each calendar year (currently, after each rebate period) on the average price at which the manufacturer sold each covered outpatient drug in Canada, Australia, Mexico, and the European Union countries.